Legend Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Top Small-cap Stock Picks From Morgan Stanley Following the Group's Upgrade to Neutral
BMO Capital Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $90
Strategic Growth and Promising Prospects Drive Buy Rating for Legend Biotech
H.C. Wainwright Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $73
The stock price has dropped nearly 30% in three months. What is left of the legendary biotech (LEGN.US) that called off the sale?
Affected by the "acquisition storm", the stock price of legend biotech reached a high of $60.87 on July 26 and has been in a fluctuating downtrend. By the closing price on October 16, it had fallen to $44.02, a decrease of 27.68% from the peak.
